The Effect of Walking in Kidney Transplant Patients

Cardiac Disease Clinical Trial

Official title:

The Effect of Pedometer Assisted Walking on Physical Activity Level and Metabolic Parameters in Patients With Renal Transplantation

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT05003193
• Other study ID #: fatma.demir1
• Status: Recruiting
• Phase: N/A
• Start date: November 19, 2020
• Est. completion date: November 2022

Study information

• Verified date: August 2021
• Source: Ege University
• Contact: Fatma DEMIR KORKMAZ, Professor
• Phone: +902323115506
• Email: fatma.demir[@]ege.edu.tr
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Cardiovascular diseases are among the most common causes of death in kidney transplant patients. Physical activity is of great importance in preventing cardiovascular diseases after transplantation. Although regular physical activity is recommended in international guidelines to prevent post-transplant mortality and morbidity in kidney transplant patients, studies have shown that patients do not follow regular physical activity instructions.The aim of our project is to examine the effect of pedometer-assisted physical activity on metabolic parameters after kidney transplantation.

Description:

Patients with kidney transplant surgery will be randomized to the intervention (n: 34) and control groups (n: 34), respectively, according to the transplant surgery date. Intervention and Control groups will be given the same training on the importance of physical activity during discharge training. The pedometer will be given to the intervention group to evaluate the activity level, and it will be said that their goal is to take 2000 steps in 20 minutes a day after discharge. Patients will be asked to carry the pedometer during physical activity, and to write down the number of steps they take in 20 minutes on the form given to them for 90 days. Patients in the control group will only be advised to do physical activity every day and will be asked to record the minutes of physical activity they do for 90 days. Metabolic parameters of the patients in the intervention and control groups will be examined at the end of the 4th and 12th months. These parameters are blood pressure, body mass index, complete blood count (hemoglobin, leukocyte, thrombocyte), blood glucose, sodium, potassium, calcium, liver enzymes, serum creatinine, total and indirect bilirubin, albumin and total cholesterol levels.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 68
• Est. completion date: November 2022
• Est. primary completion date: November 2022
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years to 65 Years

Eligibility

Inclusion Criteria: • Over the age of 18 and under the age of 65,

• Kidney transplantation at the center where the study was conducted between the research dates,

• There is no activity restriction recommendation by the physician,

• Patients who agree to participate in the study.

Exclusion Criteria:

• Multiple organ transplantation at the same time,

• Death or graft loss/rejection in the hospital before discharge,

• Patients with physical activity restrictions by the physician,

• Patients who are re-hospitalized within the first 3 months after discharge

Related Conditions & MeSH terms

• Cardiac Disease
• Heart Diseases
• Kidney Transplant; Complications

Intervention

Device:
• pedometer
2000 steps per day in 20 minutes for 90 days, guided by a pedometer after a kidney transplantation

Locations

Country	Name	City	State
Turkey	Ege University	Izmir

Sponsors (1)

Lead Sponsor	Collaborator
Ege University

Country where clinical trial is conducted

Turkey, 

References & Publications (13)

Aakhus S, Dahl K, Widerøe TE. Cardiovascular disease in stable renal transplant patients in Norway: morbidity and mortality during a 5-yr follow-up. Clin Transplant. 2004 Oct;18(5):596-604. — View Citation

Berben L, Engberg SJ, Rossmeissl A, Gordon EJ, Kugler C, Schmidt-Trucksäss A, Klem ML, Sereika SM, De Simone P, Dobbels F, De Geest SM; B-SERIOUS consortium. Correlates and Outcomes of Low Physical Activity Posttransplant: A Systematic Review and Meta-Analysis. Transplantation. 2019 Apr;103(4):679-688. doi: 10.1097/TP.0000000000002543. — View Citation

Dontje ML, de Greef MH, Krijnen WP, Corpeleijn E, Kok T, Bakker SJ, Stolk RP, van der Schans CP. Longitudinal measurement of physical activity following kidney transplantation. Clin Transplant. 2014 Apr;28(4):394-402. doi: 10.1111/ctr.12325. Epub 2014 Mar 17. — View Citation

Gordon EJ, Prohaska TR, Gallant MP, Sehgal AR, Strogatz D, Yucel R, Conti D, Siminoff LA. Longitudinal analysis of physical activity, fluid intake, and graft function among kidney transplant recipients. Transpl Int. 2009 Oct;22(10):990-8. doi: 10.1111/j.1432-2277.2009.00917.x. Epub 2009 Jul 10. — View Citation

Gustaw T, Schoo E, Barbalinardo C, Rodrigues N, Zameni Y, Motta VN, Mathur S, Janaudis-Ferreira T. Physical activity in solid organ transplant recipients: Participation, predictors, barriers, and facilitators. Clin Transplant. 2017 Apr;31(4). doi: 10.1111/ctr.12929. Epub 2017 Mar 14. — View Citation

Hawkins MS, Sevick MA, Richardson CR, Fried LF, Arena VC, Kriska AM. Association between physical activity and kidney function: National Health and Nutrition Examination Survey. Med Sci Sports Exerc. 2011 Aug;43(8):1457-64. doi: 10.1249/MSS.0b013e31820c0130. — View Citation

Kidney Disease: Improving Global Outcomes (KDIGO) Transplant Work Group. KDIGO clinical practice guideline for the care of kidney transplant recipients. Am J Transplant. 2009 Nov;9 Suppl 3:S1-155. doi: 10.1111/j.1600-6143.2009.02834.x. — View Citation

Lorenz EC, Amer H, Dean PG, Stegall MD, Cosio FG, Cheville AL. Adherence to a pedometer-based physical activity intervention following kidney transplant and impact on metabolic parameters. Clin Transplant. 2015 Jun;29(6):560-8. doi: 10.1111/ctr.12553. Epub 2015 May 26. — View Citation

Nelson ME, Rejeski WJ, Blair SN, Duncan PW, Judge JO, King AC, Macera CA, Castaneda-Sceppa C; American College of Sports Medicine; American Heart Association. Physical activity and public health in older adults: recommendation from the American College of Sports Medicine and the American Heart Association. Circulation. 2007 Aug 28;116(9):1094-105. Epub 2007 Aug 1. — View Citation

Ojo AO. Cardiovascular complications after renal transplantation and their prevention. Transplantation. 2006 Sep 15;82(5):603-11. Review. — View Citation

Svensson M, Jardine A, Fellström B, Holdaas H. Prevention of cardiovascular disease after renal transplantation. Curr Opin Organ Transplant. 2012 Aug;17(4):393-400. doi: 10.1097/MOT.0b013e3283560a3b. Review. — View Citation

Zelle DM, Corpeleijn E, Klaassen G, Schutte E, Navis G, Bakker SJ. Fear of Movement and Low Self-Efficacy Are Important Barriers in Physical Activity after Renal Transplantation. PLoS One. 2016 Feb 4;11(2):e0147609. doi: 10.1371/journal.pone.0147609. eCollection 2016. — View Citation

Zelle DM, Kok T, Dontje ML, Danchell EI, Navis G, van Son WJ, Bakker SJ, Corpeleijn E. The role of diet and physical activity in post-transplant weight gain after renal transplantation. Clin Transplant. 2013 Jul-Aug;27(4):E484-90. doi: 10.1111/ctr.12149. Epub 2013 Jun 13. — View Citation

* Note: There are 13 references in all — Click here to view all references

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Blood Pressure	mmHg	Change from Baseline Blood Pressure at 4 months after discharge
Primary	Blood Pressure	mmHg	Change from Baseline Blood Pressure at 12 months after discharge
Primary	Body Mass Index (BMI)	BMI is weight in kilograms divided by height in meters squared. Formula: weight (kg) / [height (m)]2	Change from Baseline BMI at 4 months after discharge
Primary	Body Mass Index (BMI)	BMI is weight in kilograms divided by height in meters squared. Formula: weight (kg) / [height (m)]2	Change from Baseline BMI at 12 months after discharge
Primary	Hemoglobin	g/dL	Change from Baseline Hemoglobin at 4 months after discharge
Primary	Hemoglobin	g/dL	Change from Baseline Hemoglobin at 12 months after discharge
Primary	Leukocyte	10^3/µL	Change from Baseline Leukocyte at 4 months after discharge
Primary	Leukocyte	10^3/µL	Change from Baseline Leukocyte at 12 months after discharge
Primary	Thrombocyte	10^3/µL	Change from Baseline Thrombocyte at 4 months after discharge
Primary	Thrombocyte	10^3/µL	Change from Baseline Thrombocyte at 12 months after discharge
Primary	Blood Glucose	mg/dL	Change from Baseline Blood Glucose at 4 months after discharge
Primary	Blood Glucose	mg/dL	Change from Baseline Blood Glucose at 12 months after discharge
Primary	Sodium	mEq/L	Change from Baseline Sodium at 4 months after discharge
Primary	Sodium	mEq/L	Change from Baseline Sodium at 12 months after discharge
Primary	Potassium	mEq/L	Change from Baseline Sodium at 4 months after discharge
Primary	Potassium	mEq/L	Change from Baseline Sodium at 12 months after discharge
Primary	Calcium	mEq/L	Change from Baseline Sodium at 4 months after discharge
Primary	Calcium	mEq/L	Change from Baseline Sodium at 12 months after discharge
Primary	Serum Creatinine	mg/dL	Change from Baseline Sodium at 4 months after discharge
Primary	Serum Creatinine	mg/dL	Change from Baseline Sodium at 12 months after discharge
Primary	Total Bilirubin	mg/dL	Change from Baseline Sodium at 4 months after discharge
Primary	Total Bilirubin	mg/dL	Change from Baseline Sodium at 12 months after discharge
Primary	Indirect Bilirubin	mg/dL	Change from Baseline Sodium at 4 months after discharge
Primary	Indirect Bilirubin	mg/dL	Change from Baseline Sodium at 12 months after discharge
Primary	High-density lipoprotein (HDL) cholesterol	mg/dL	Change from Baseline Sodium at 4 months after discharge
Primary	High-density lipoprotein (HDL) cholesterol	mg/dL	Change from Baseline Sodium at 12 months after discharge
Primary	Low-density lipoprotein (LDL) cholesterol	mg/dL	Change from Baseline Sodium at 4 months after discharge
Primary	Low-density lipoprotein (LDL) cholesterol	mg/dL	Change from Baseline Sodium at 12 months after discharge
Primary	Aspartate Aminotransferase	U/L	Change from Baseline Sodium at 4 months after discharge
Primary	Aspartate Aminotransferase	U/L	Change from Baseline Sodium at 12 months after discharge
Primary	Alanine aminotransferase	U/L	Change from Baseline Sodium at 4 months after discharge
Primary	Alanine aminotransferase	U/L	Change from Baseline Sodium at 12 months after discharge
Primary	Alkaline Phosphatase	U/L	Change from Baseline Sodium at 4 months after discharge
Primary	Alkaline Phosphatase	U/L	Change from Baseline Sodium at 12 months after discharge
Primary	Triglyceride	mg/dL	Change from Baseline Sodium at 4 months after discharge
Primary	Triglyceride	mg/dL	Change from Baseline Sodium at 12 months after discharge
Primary	Total Cholesterol	mg/dL	Change from Baseline Sodium at 4 months after discharge
Primary	Total Cholesterol	mg/dL	Change from Baseline Sodium at 12 months after discharge
Primary	Albumin	g/dL	Change from Baseline Sodium at 4 months after discharge
Primary	Albumin	g/dL	Change from Baseline Sodium at 12 months after discharge
Primary	glucose in urine	mg/dL	Change from Baseline Sodium at 4 months after discharge
Primary	glucose in urine	mg/dL	Change from Baseline Sodium at 12 months after discharge